«
Personal neoantigen vaccine prompts strong anti-tumor response in patients, study shows.»
Not exact matches
Then they made each patient a
personal vaccine containing about 20 of these
neoantigens.
The researchers found that the
personal vaccine induced a focused T cell response against several tumor
neoantigens, beyond what is normally seen in response to existing immunotherapies.
Applying this tool to the six patients» tumor samples yielded dozens of unique
neoantigens for each patient's
personal vaccine.
A
personal cancer treatment vaccine that targets distinctive «
neoantigens» on tumor cells has been shown to stimulate a potent, safe, and highly specific immune anti-tumor response in melanoma patients, report scientists from Dana - Farber Cancer Institute and the Broad Institute of MIT and Harvard.